Advances in umbilical cord blood stem cell expansion and clinical translation

Experimental Hematology

Volumn 43, Issue 7, 2015, Pages 498-513

  Pineault, Nicolas ^a,b   Abu Khader, Ahmad ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DECITABINE; TRICHOSTATIN A; MOLECULAR LIBRARY; SIGNAL PEPTIDE;

CELL ENGINEERING; CELL HOMING; CELL TRACKING; CLINICAL PROTOCOL; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; CULTURE TECHNIQUE; CYTOLOGY; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; LENGTH OF STAY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; STEM CELL EXPANSION; TREATMENT RESPONSE; UMBILICAL CORD BLOOD; ANIMAL; CELL CULTURE; CELL DIVISION; CELL MOTION; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; FETUS BLOOD; GENETIC ASSOCIATION; GENETICS; GRAFT SURVIVAL; IMMUNOPHENOTYPING; MOLECULAR LIBRARY; MOUSE; NONOBESE DIABETIC MOUSE; PROCEDURES; SCID MOUSE; SIGNAL TRANSDUCTION; STROMA CELL; TRANSLATIONAL RESEARCH; TRANSPLANTATION; TREATMENT OUTCOME; XENOGRAFT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINES; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; FETAL BLOOD; GENETIC ASSOCIATION STUDIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; HETEROGRAFTS; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; STROMAL CELLS; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84930802993     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2015.04.011     Document Type: Review

References (174)

1. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961, 14:213-222.
2. Lu R., Neff N.F., Quake S.R., Weissman I.L. Tracking single hematopoietic stem cells invivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat Biotechnol 2011, 29:928-933.
3. Cheung A.M., Nguyen L.V., Carles A., et al. Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood 2013, 122:3129-3137.
4. Gerrits A., Dykstra B., Kalmykowa O.J., et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010, 115:2610-2618.
5. Benz C., Copley M.R., Kent D.G., et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell stem cell 2012, 10:273-283.
6. Doulatov S., Notta F., Laurenti E., Dick J.E. Hematopoiesis: A human perspective. Cell Stem Cell 2012, 10:120-136.
7. Schmitz N., Linch D.C., Dreger P., et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996, 347:353-357.
8. Korbling M., Freireich E.J. Twenty-five years of peripheral blood stem cell transplantation. Blood 2011, 117:6411-6416.
9. Oran B., Shpall E. Umbilical cord blood transplantation: A maturing technology. Hematology 2012, 2012:215-222.
10. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
11. Gratwohl A., Baldomero H., Aljurf M., et al. Hematopoietic stem cell transplantation: A global perspective. JAMA 2010, 303:1617-1624.
12. Wagner J.E., Eapen M., Carter S., et al. One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med 2014, 371:1685-1694.
13. Ballen K.K., Gluckman E., Broxmeyer H.E. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013, 122:491-498.
14. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
15. Barker J.N., Weisdorf D.J., Wagner J.E. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001, 344:1870-1871.
16. Scaradavou A., Brunstein C.G., Eapen M., et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013, 121:752-758.
17. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
18. Eapen M., Klein J.P., Ruggeri A., et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014, 123:133-140.
19. Szilvassy S.J., Weller K.P., Chen B., Juttner C.A., Tsukamoto A., Hoffman R. Partially differentiated exvivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood 1996, 88:3642-3653.
20. Na Nakorn T., Traver D., Weissman I.L., Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 2002, 109:1579-1585.
21. Arber C., Bitmansour A., Shashidhar S., Wang S., Tseng B., Brown J.M. Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. J Infect Dis 2005, 192:1666-1671.
22. BitMansour A., Burns S.M., Traver D., et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 2002, 100:4660-4667.
23. Coulombel L. Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene 2004, 23:7210-7222.
24. Majeti R., Park C.Y., Weissman I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007, 1:635-645.
25. Copley M.R., Beer P.A., Eaves C.J. Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell 2012, 10:690-697.
26. Szilvassy S.J., Nicolini F.E., Eaves C.J., Miller C.L. Quantitation of murine and human hematopoietic stem cells by limiting-dilution analysis in competitively repopulated hosts. Hematopoietic Stem Cell Protocols 2002, 167-187. Humana Press, Totowa, NJ. C.A. Klug, C.T. Jordan (Eds.).
27. Shultz L.D., Lyons B.L., Burzenski L.M., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005, 174:6477-6489.
28. Yahata T., Ando K., Nakamura Y., et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 2002, 169:204-209.
29. Fares I., Chagraoui J., Gareau Y., et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 2014, 345:1509-1512.
30. Liu C., Chen B.J., Deoliveira D., Sempowski G.D., Chao N.J., Storms R.W. Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. Blood 2010, 116:5518-5527.
31. Wu C., Li B., Lu R., et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014, 14:486-499.
32. Mendelson A., Frenette P.S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med 2014, 20:833-846.
33. Yin T., Li L. The stem cell niches in bone. J Clin Invest 2006, 116:1195-1201.
34. Dexter T.M., Allen T.D., Lajtha L.G. Conditions controlling the proliferation of haemopoietic stem cells invitro. J Cell Physiol 1977, 91:335-344.
35. Dexter T.M., Moore M.A., Sheridan A.P. Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras invitro. J Exp Med 1977, 145:1612-1616.
36. Yamaguchi M., Hirayama F., Kanai M., et al. Serum-free coculture system for exvivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol 2001, 29:174-182.
37. Deryugina E.I., Muller-Sieburg C.E. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development?. Crit Rev Immunol 1993, 13:115-150.
38. Kawano Y., Kobune M., Yamaguchi M., et al. Exvivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 2003, 101:532-540.
39. Thiemann F.T., Moore K.A., Smogorzewska E.M., Lemischka I.R., Crooks G.M. The murine stromal cell line AFT024 acts specifically on human CD34+CD38- progenitors to maintain primitive function and immunophenotype invitro. Exp Hematol 1998, 26:612-619.
40. Shih C.C., Hu M.C., Hu J., Medeiros J., Forman S.J. Long-term exvivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 1999, 94:1623-1636.
41. Rafii S., Shapiro F., Pettengell R., et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
42. Li W., Johnson S.A., Shelley W.C., Yoder M.C. Hematopoietic stem cell repopulating ability can be maintained invitro by some primary endothelial cells. Exp Hematol 2004, 32:1226-1237.
43. Butler J.M., Gars E.J., James D.J., Nolan D.J., Scandura J.M., Rafii S. Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. Blood 2012, 120:1344-1347.
44. Butler J.M., Nolan D.J., Vertes E.L., et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 2010, 6:251-264.
45. Rosler E., Brandt J., Chute J., Hoffman R. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells. Exp Hematol 2000, 28:841-852.
46. Fei X.M., Wu Y.J., Chang Z., et al. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Cytotherapy 2007, 9:338-347.
47. Goncalves R., Lobato da Silva C., Cabral J.M., Zanjani E.D., Almeida-Porada G. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Exp Hematol 2006, 34:1353-1359.
48. Khoury M., Drake A., Chen Q., et al. Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential. Stem Cells Dev 2011, 20:1371-1381.
49. Walenda T., Bokermann G., Ventura Ferreira M.S., et al. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp Hematol 2011, 39:617-628.
50. + cells improves the maintenance and proliferative capacity of hematopoietic stem cells. J Cell Physiol 2012, 227:2750-2758.
51. Celebi B., Mantovani D., Pineault N. Effects of extracellular matrix proteins on the growth of haematopoietic progenitor cells. Biomed Mater 2011, 6:055011.
52. Liu M., Yang S.G., Shi L., et al. Mesenchymal stem cells from bone marrow show a stronger stimulating effect on megakaryocyte progenitor expansion than those from non-hematopoietic tissues. Platelets 2010, 21:199-210.
53. Amsellem S., Pflumio F., Bardinet D., et al. Exvivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003, 9:1423-1427.
54. Isern J., Martin-Antonio B., Ghazanfari R., et al. Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell Rep 2013, 3:1714-1724.
55. Da Silva C.L., Goncalves R., Crapnell K.B., Cabral J.M., Zanjani E.D., Almeida-Porada G. A human stromal-based serum-free culture system supports the exvivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 2005, 33:828-835.
56. Dumont N., Boyer L., Émond H., et al. Medium conditioned with mesenchymal stromal cell-derived osteoblasts improves the expansion and engraftment properties of cord blood progenitors. Exp Hematol 2014, 42:741-752.e741.
57. Breems D.A., Blokland E.A., Siebel K.E., Mayen A.E., Engels L.J., Ploemacher R.E. Stroma-contact prevents loss of hematopoietic stem cell quality during exvivo expansion of CD34+ mobilized peripheral blood stem cells. Blood 1998, 91:111-117.
58. Flores-Guzman P., Flores-Figueroa E., Montesinos J.J., et al. Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the invitro growth of primitive hematopoietic cells from human umbilical cord blood. Cytotherapy 2009, 11:886-896.
59. McNiece I., Harrington J., Turney J., Kellner J., Shpall E.J. Exvivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 2004, 6:311-317.
60. + hematopoietic stem cells and for chondrogenic differentiation. Haematologica 2004, 89:837-844.
61. + cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World J Gastroenterol 2006, 12:393-402.
62. Jang Y.K., Jung D.H., Jung M.H., et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for exvivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006, 85:212-225.
63. Kawada H., Ando K., Tsuji T., et al. Rapid exvivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 1999, 27:904-915.
64. Li N., Feugier P., Serrurrier B., et al. Human mesenchymal stem cells improve exvivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp Hematol 2007, 35:507-515.
65. Çelebi B., Mantovani D., Pineault N. Irradiated mesenchymal stem cells improve the exvivo expansion of hematopoietic progenitors by partly mimicking the bone marrow endosteal environment. J Immunol Methods 2011, 370:93-103.
66. Verfaillie C.M. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term invitro hematopoiesis. Blood 1992, 79:2821-2826.
67. Verfaillie C.M. Adhesion receptors as regulators of the hematopoietic process [comment]. Blood 1998, 92:2609-2612.
68. Ferreira M.S., Jahnen-Dechent W., Labude N., et al. Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support. Biomaterials 2012, 33:6987-6997.
69. Madkaikar M., Ghosh K., Gupta M., Swaminathan S., Mohanty D. Exvivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol 2007, 118:153-159.
70. Robinson S.N., Ng J., Niu T., et al. Superior exvivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant 2006, 37:359-366.
71. Schinkothe T., Bloch W., Schmidt A. Invitro secreting profile ofhuman mesenchymal stem cells. Stem Cells Dev 2008, 17:199-206.
72. Nagahisa H., Nagata Y., Ohnuki T., et al. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 1996, 87:1309-1316.
73. Wagner W., Roderburg C., Wein F., et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem cells 2007, 25:2638-2647.
74. Ogawa M. Hemopoietic stem cells: stochastic differentiation and humoral control of proliferation. Environ Health Perspect 1989, 80:199-207.
75. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998, 176:57-66.
76. De Lima M., McNiece I., Robinson S.N., et al. Cord-blood engraftment with exvivo mesenchymal-cell coculture. N Engl J Med 2012, 367:2305-2315.
77. Sauvageau G., Iscove N.N., Humphries R.K. Invitro and invivoexpansion of hematopoietic stem cells. Oncogene 2004, 23:7223-7232.
78. Lotem J., Sachs L. Cytokine control of developmental programs innormal hematopoiesis and leukemia. Oncogene 2002, 21:3284-3294.
79. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002, 21:3295-3313.
80. Metcalf D. Hematopoietic cytokines. Blood 2008, 111:485-491.
81. Bhatia M., Bonnet D., Kapp U., Wang J.C., Murdoch B., Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term exvivo culture. J Exp Med 1997, 186:619-624.
82. -/low) cells capable of repopulating severe combined immunodeficiency mice. Blood 1999, 94:923-931.
83. + cord blood cells after exvivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999, 93:3736-3749.
84. Rossmanith T., Schroder B., Bug G., et al. Interleukin 3 improves the exvivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Stem Cells 2001, 19:313-320.
85. Ueda T., Tsuji K., Yoshino H., et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 2000, 105:1013-1021.
86. Rollini P., Kaiser S., Faes-van't Hull E., Kapp U., Leyvraz S. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood 2004, 103:1166-1170.
87. Zhang C.C., Kaba M., Iizuka S., Huynh H., Lodish H.F. Angiopoietin-like 5 and IGFBP2 stimulate exvivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008, 111:3415-3423.
88. Liu B., Chen J.S., Cao M., et al. Platelet characteristic antigens of CD34+ cells in cryopreserved cord blood: A study of platelet-derived microparticles in transplant processing. Vox Sang 2004, 87:96-104.
89. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
90. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., Eaves C.J. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 1997, 94:4698-4703.
91. Luens K.M., Travis M.A., Chen B.P., Hill B.L., Scollay R., Murray L.J. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 1998, 91:1206-1215.
92. Murray L.J., Luens K.M., Estrada M.F., et al. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis. Exp Hematol 1998, 26:207-216.
93. - bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine invivo long-term reconstituting stem cells. Blood 1999, 94:4093-4102.
94. Glimm H., Eaves C.J. Direct evidence for multiple self-renewal divisions of human invivo repopulating hematopoietic cells in short-term culture. Blood 1999, 94:2161-2168.
95. Duchez P., Dazey B., Douay L., Vezon G., Ivanovic Z. An efficient large-scale thawing procedure for cord blood cells destined for selection and exvivo expansion of CD34+ cells. J Hematother Stem Cell Res 2003, 12:587-589.
96. Audet J., Miller C.L., Eaves C.J., Piret J.M. Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng 2002, 80:393-404.
97. Pineault N., Cortin V., Boyer L., et al. Individual and synergistic cytokine effects controlling the expansion of cord blood CD34+ cells and megakaryocyte progenitors in culture. Cytotherapy 2011, 13:467-480.
98. Zhang C.C., Kaba M., Ge G., et al. Angiopoietin-like proteins stimulate exvivo expansion of hematopoietic stem cells. Nat Med 2006, 12:240-245.
99. Kobayashi H., Butler J.M., O'Donnell R., et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2010, 12:1046-1056.
100. Huynh H., Iizuka S., Kaba M., et al. Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell line supports exvivo expansion of mouse hematopoietic stem cells. Stem Cells 2008, 26:1628-1635.
101. Bhatia M., Bonnet D., Wu D., et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 1999, 189:1139-1148.
102. Bhardwaj G., Murdoch B., Wu D., et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001, 2:172-180.
103. - cord blood cells. J Clin Invest 2002, 110:1165-1174.
104. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R.L., Bernstein I.D. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010, 16:232-236.
105. Karanu F.N., Murdoch B., Gallacher L., et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000, 192:1365-1372.
106. Benveniste P., Serra P., Dervovic D., et al. Notch signals are required for invitro but not invivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors. Blood 2014, 123:1167-1177.
107. Varnum-Finney B., Wu L., Yu M., et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci 2000, 113(Pt 23):4313-4318.
108. Delaney C., Varnum-Finney B., Aoyama K., Brashem-Stein C., Bernstein I.D. Dose-dependent effects of the Notch ligand Delta1 on exvivo differentiation and invivo marrow repopulating ability of cord blood cells. Blood 2005, 106:2693-2699.
109. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells exvivo. Cell 2002, 109:39-45.
110. Buske C., Feuring-Buske M., Abramovich C., et al. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 2002, 100:862-868.
111. Sauvageau G., Thorsteinsdottir U., Eaves C.J., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations invitro and invivo. Genes Dev 1995, 9:1753-1765.
112. Krosl J., Austin P., Beslu N., Kroon E., Humphries R.K., Sauvageau G. Invitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003, 9:1428-1432.
113. Huang C.H., Chen P.M., Lu T.C., et al. Purified recombinant TAT-homeobox B4 expands CD34(+) umbilical cord blood and peripheral blood progenitor cells exvivo. Tissue Eng Part C Methods 2010, 16:487-496.
114. Csaszar E., Kirouac D.C., Yu M., et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 2012, 10:218-229.
115. Araki H., Mahmud N., Milhem M., et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol 2006, 34:140-149.
116. Boitano A.E., Wang J., Romeo R., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348.
117. Chen X., Skutt-Kakaria K., Davison J., et al. G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev 2012, 26:2499-2511.
118. Peled T., Shoham H., Aschengrau D., et al. Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol 2012, 40:342-355-e341.
119. Milhem M., Mahmud N., Lavelle D., et al. Modification of hematopoietic stem cell fate by 5-aza 2'-deoxycytidine and trichostatin A. Blood 2004, 103:4102-4110.
120. De Felice L., Tatarelli C., Mascolo M.G., et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res 2005, 65:1505-1513.
121. Aguila J.R., Liao W., Yang J., et al. SALL4 is a robust stimulator for the expansion of hematopoietic stem cells. Blood 2011, 118:576-585.
122. Tatetsu H., Wang F., Gao C., et al. SALL4 Is a Key Factor in HDAC Inhibitor mediated exvivo expansion of human peripheral blood mobilized stem/progenitor CD34+CD90+ cells. Blood 2014, 124:1566.
123. Peled T., Landau E., Prus E., Treves A.J., Nagler A., Fibach E. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol 2002, 116:655-661.
124. Peled T., Landau E., Mandel J., et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term exvivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004, 32:547-555.
125. Marquez-Curtis L.A., Turner A.R., Sridharan S., Ratajczak M.Z., Janowska-Wieczorek A. The ins and outs of hematopoietic stem cells: Studies to improve transplantation outcomes. Stem Cell Rev 2011, 7:590-607.
126. Hagedorn E.J., Durand E.M., Fast E.M., Zon L.I. Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2. Exp Cell Res 2014, 329:220-226.
127. Hoggatt J., Singh P., Sampath J., Pelus L.M. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009, 113:5444-5455.
128. North T.E., Goessling W., Walkley C.R., et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447:1007-1011.
129. Wu W., Kim C.H., Liu R., et al. The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 2012, 26:736-745.
130. Christopherson K.W., Hangoc G., Mantel C.R., Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004, 305:1000-1003.
131. Trowbridge J.J., Xenocostas A., Moon R.T., Bhatia M. Glycogen synthase kinase-3 is an invivo regulator of hematopoietic stem cell repopulation. Nat Med 2006, 12:89-98.
132. Bug G., Gul H., Schwarz K., et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 2005, 65:2537-2541.
133. Seet L.F., Teng E., Lai Y.S., et al. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Eur J Haematol 2009, 82:124-132.
134. Gul H., Marquez-Curtis L.A., Jahroudi N., Lo J., Turner A.R., Janowska-Wieczorek A. Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling. Stem Cells Dev 2009, 18:831-838.
135. Robbins D., Le T., Troung C., et al. Ex Vivo modulation of mobilized peripheral blood: Characterization of HSC and T-cell responses to Prostaglandin E2. Blood 2014, 124. 1092.
136. Ratajczak J., Reca R., Kucia M., et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 2004, 103:2071-2078.
137. Reca R., Mastellos D., Majka M., et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003, 101:3784-3793.
138. Goessling W., Allen R.S., Guan X., et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011, 8:445-458.
139. Christopherson K.W., Hangoc G., Broxmeyer H.E. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002, 169:7000-7008.
140. + cell interactions with bone marrow endothelium are enhanced postnatally. J Clin Invest 2002, 110:559-569.
141. Xia L., McDaniel J.M., Yago T., Doeden A., McEver R.P. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 2004, 104:3091-3096.
142. Farag S.S., Srivastava S., Messina-Graham S., et al. Invivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev 2013, 22:1007-1015.
143. Cutler C., Multani P., Robbins D., et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 2013, 122:3074-3081.
144. Robbins D, Le T, Troung C, etal. Exvivo modulation of mobilized peripheral blood: Characterization of HSC and T-cell responses to prostaglandin E2.2014.
145. Popat U., Mehta R.S., Rezvani K., et al. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood 2015, 125:2885-2892.
146. + cells facilitates myeloid and megakaryocytic engraftment in the non-obese diabetic severe combined immunodeficient mouse model. Br J Haematol 2001, 114:433-443.
147. Dahlberg A., Brashem-Stein C., Delaney C., Bernstein I.D. Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1Ext-IgG. Leukemia 2014, 28:2097-2101.
148. Feng Y., Zhang L., Xiao Z.J., et al. An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol 2005, 33:1537-1543.
149. Van Hensbergen Y., Schipper L.F., Brand A., et al. Exvivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol 2006, 34:943-950.
150. Mattia G., Milazzo L., Vulcano F., et al. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol 2008, 36:244-252.
151. Emond H., Boyer L., Roy D.C., Pineault N. Co-transplantation of exvivo expanded progenitors with non-expanded cord blood cells improves platelet recovery. Stem Cells Dev 2012, 21:3209-3219.
152. Schipper L.F., Brand A., Fibbe W.E., Van Hensbergen Y. Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD6- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells. Stem Cells 2012, 30:988-996.
153. Pineault N., Boyer L. Cellular-based therapies to prevent or reduce thrombocytopenia. Transfusion 2011, 51(Suppl 4):72S-81S.
154. Bruno S., Gunetti M., Gammaitoni L., et al. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Stem Cells 2004, 22:135-143.
155. Fuentes R., Wang Y., Hirsch J., et al. Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest 2010, 120:3917-3922.
156. Emerson S.G., Sieff C.A., Gross R.G., et al. Decreased hematopoietic accessory cell function following bone marrow transplantation. Exp Hematol 1987, 15:1013-1021.
157. Verstegen M.M.A., van Hennik P.B., Terpstra W., et al. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: Evidence for accessory cell involvement in expansion of immature CD34+CD38- cells. Blood 1998, 91:1966-1976.
158. Schibler K.R., Li Y., Ohls R.K., et al. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood 1994, 84:3679-3684.
159. + cells are functionally active in an exvivo flow model of thrombosis. Blood 2009, 114:5044-5051.
160. Shpall E.J., Quinones R., Giller R., et al. Transplantation of exvivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8:368-376.
161. Jaroscak J., Goltry K., Smith A., et al. Augmentation of umbilical cord blood (UCB) transplantation with exvivo-expanded UCB cells: Results of a phase 1 trial using the AastromReplicell System. Blood 2003, 101:5061-5067.
162. De Lima M., McMannis J., Gee A., et al. Transplantation of exvivo expanded cord blood cells using the copper chelator tetraethylenepentamine: A phase I/II clinical trial. Bone Marrow Transplant 2008, 41:771-778.
163. Horwitz M.E., Chao N.J., Rizzieri D.A., et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest 2014, 124:3121-3128.
164. Wagner J.E., Brunstein C., McKenna D., et al. Acceleration of umbilical cord blood (UCB) Stem engraftment: Results of a phase I clinical trial with Stemregenin-1 (SR1) expansion culture. Biol Blood Marrow Transplant 2015, 21:S48-S49.
165. Ko K.H., Nordon R., O'Brien T.A., Symonds G., Dolnikov A. Exvivo expansion of haematopoietic stem cells to improve engraftment in stem cell transplantation. Methods Mol Biol 2011, 761:249-260.
166. Pecora A., Stiff P., Jennis A., et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using exvivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000, 25:797-799.
167. Fernandez M.N., Granena A., Millan I., et al. Evaluation of engraftment of exvivo expanded cord blood cells in humans. Bone Marrow Transplant 2000, 25(Suppl 2):S61-S67.
168. Kogler G., Nurnberger W., Fischer J., et al. Simultaneous cord blood transplantation of exvivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999, 24:397-403.
169. Milano F., Heimfeld S., Riffkin I.B., et al. Infusion of a non HLA-matched off-the-shelf ex vivo expanded cord blood progenitor cell product following myeloablative cord blood transplantation is safe, decreases the time to hematopoietic recovery, and results in excellent overall survival. Blood 2014, 124:46.
170. Summers C., Milano F., Gooley T.A., Dahlberg A., Delaney C. Infusion of ex vivo expanded cord blood progenitor cells reduces the risk of bacteremia after myeloablative cord blood transplant. Blood 2014, 124:3860.
171. Brunstein CG, McKenna D, Sumstad D, etal. Safety and exploratory efficacy of exvivo expanded umbilical cord blood (UCB) hematopoietic stem and progenitor cells (HSPC) Using Cytokines and Stem-Regenin 1 (SR1): Interim results of a phase 1/2 dose escalation clinical study. Presented at the 55th ASH Annual Meeting and Exposition, New Orleans, Louisiana, December 7-10,2013.
172. Yahata T., Ando K., Miyatake H., et al. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice. Mol Ther 2004, 10:882-891.
173. Eldjerou L.K., Chaudhury S., Baisre-de Leon A., et al. An invivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood 2010, 116:3999-4006.
174. Gutman J.A., Turtle C.J., Manley T.J., et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood 2010, 115:757-765.